Table 3 Baseline treatment practice characteristics
Whole Cohort | Propensity Matched Cohort | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
Treatment Practices | Non-Māori, n (%) n = 3312 | Māori, n (%) n = 1459 | Risk ratio | 95% CI | Standardised difference | Non-Māori, n (%) n = 1026 | Māori, n (%) n = 1039 | Risk Ratio | 95% CI | Standardised difference |
Modality of first treatment | ||||||||||
Peritoneal Dialysis | 1110 (34) | 420 (29) | 1.16 | 1.06–1.28 | 0.11 | 420 (29) | 418 (29) | 1.02 | 0.92–1.13 | 0 |
Haemodialysis | 2063 (62) | 1027 (70) | 0.88 | 0.85–0.92 | −0.17 | 998 (69) | 1015 (70) | 0.99 | 0.97–1.00 | −0.02 |
Transplant | 139 (4) | 12 (1) | 5.10 | 2.84–9.17 | 0.19 | 27 (2) | 12 (1) | 2.28 | 1.16–4.47 | 0.08 |
*Haemodialysis vascular access | ||||||||||
Arteriovenous fistula | 468 (26) | 206 (23) | 1.12 | 0.97–1.30 | 0.07 | 224 (26) | 205 (23) | 1.12 | 0.95–1.32 | 0.07 |
Arteriovenous graft | 21 (1) | 18 (2) | 0.58 | 0.31–1.08 | −0.08 | 11 (1) | 18 (2) | 0.62 | 0.30–1.31 | − 0.08 |
Tunnelled central venous catheter | 546 (30) | 247 (28) | 1.09 | 0.96–1.24 | 0.04 | 288 (33) | 242 (28) | 1.22 | 1.05–1.40 | 0.11 |
Non-tunnelled central venous catheter | 766 (43) | 419 (47) | 0.90 | 0.83–0.99 | −0.08 | 337 (30) | 414 (47) | 0.83 | 0.75–0.93 | −0.35 |
Referral practices | ||||||||||
Referral to specialist services within 3 months of starting treatment | 620 (19) | 371 (25) | 0.74 | 0.65–0.82 | −0.15 | 365 (25) | 293 (20) | 1.26 | 1.11–1.43 | 0.12 |